INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
6.61
+0.39 (6.27%)
At close: Jun 24, 2025, 4:00 PM
6.68
+0.07 (1.06%)
After-hours: Jun 24, 2025, 7:51 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $153.42 million as of June 24, 2025. Its market cap has decreased by -13.35% in one year.
Market Cap
153.42M
Enterprise Value
134.43M
1-Year Change
-13.35%
Ranking
Category
Stock Price
$6.61
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $153.42M, an increase of 97.14%. That is a compound annual growth rate of 11.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |